Answers are grounded in this paper and cite their sources.
This minireview series reviews some of the most recent findings about quinolinic acid's cellular toxicity and its implications in diseases such as HIV associated neurocognitive disorders, depressive disorders and schizophrenia, and finally therapeutic strategies with drugs able to interfere with quinolinic acid production and/or effects.
No takes yet. Share an insight, caveat, or question.
Gilles J. Guillemin (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: